A newly developed radiopharmaceutical pair can precisely detect and effectively treat gastric and pancreatic tumors, ...

According to new research, radiation therapy administered before surgery rarely produces favorable responses in patients with ...

Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...

Profound is a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue.

Ovarian cancer reprograms the omentum to shield hidden tumors. New research suggests total omentectomy may curb recurrence and improve long-term outcomes.

Preterm births are rising in Nepal as more couples marry and have children later in life, increasing health risks for ...

Surgeons in Los Angeles expected to remove a massive 22-pound growth from a pregnant woman's abdomen. Instead, they uncovered ...

Gynecological morbidities are critical components of reproductive health and significantly contribute to the disease burden ...

Acrivon Therapeutics shares new trial data showing strong cancer responses, early tumor shrinkage, and pipeline progress, ...

Electronic data capture (EDC) extract from the ongoing ACR-368 registrational-intent Phase 2b monotherapy trial in OncoSignature-positive (BM+) subjects with endometrial cancer (EC) showed 39% overall ...

Thousands of women are now suing pharmaceutical giant Pfizer over claims its popular birth control injection left them with 'life-changing' brain tumors. The drug company will stand trial later this ...